Geovax Labs Inc is us-based clinical-stage biotechnology company. Geovax Labs Inc is us-based clinical-stage biotechnology company.
ATLANTA, GA, Sept. 03, 2024 (GLOBE NEWSWIRE) -- GeoVax Labs, Inc. (Nasdaq: GOVX), a biotechnology company developing immunotherapies and vaccines against cancers and infectious diseases, today...
ATLANTA, GA, Aug. 28, 2024 (GLOBE NEWSWIRE) -- GeoVax Labs, Inc. (Nasdaq: GOVX), a clinical-stage biotechnology company developing immunotherapies and vaccines against cancer and infectious...
Company to Provide a Detailed Overview of Mpox Including Commentary on the Rapid Spread and Methods for Control, Treatment, and Prevention ATLANTA, GA, Aug. 21, 2024 (GLOBE NEWSWIRE) -- GeoVax...
ATLANTA, GA, Aug. 20, 2024 (GLOBE NEWSWIRE) -- GeoVax Labs, Inc. (Nasdaq: GOVX), a clinical-stage biotechnology company developing immunotherapies and vaccines against cancer and infectious...
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | -0.84 | -23.0769230769 | 3.64 | 11.18 | 2.7401 | 12293962 | 6.86137851 | CS |
4 | 1.09 | 63.7426900585 | 1.71 | 11.18 | 1.6 | 6891518 | 5.39841625 | CS |
12 | 0.73 | 35.2657004831 | 2.07 | 11.18 | 1.0901 | 3510942 | 5.00328476 | CS |
26 | -5.9 | -67.816091954 | 8.7 | 11.18 | 1.0901 | 1866880 | 5.06709978 | CS |
52 | -69.05 | -96.1029923452 | 71.85 | 84.15 | 1.0901 | 3672928 | 27.54273943 | CS |
156 | -42.2 | -93.7777777778 | 45 | 130.65 | 1.0901 | 3167581 | 33.46581937 | CS |
260 | 0 | 0 | 0 | 3.94 | 0 | 0 | 0 | CS |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.